Compare · head to head
Daewon Pharmaceutical vs Towa Pharmaceutical
Towa Pharmaceutical ranks higher overall — 360 rank 50 vs 46.
Daewon Pharmaceutical leads on Quality (59 vs 52). Towa Pharmaceutical leads on Growth (62 vs 51) and Safety (27 vs 22). The two are close on Value and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Japan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Large |
| ISIN | KR7003220001 | JP3623150004 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 46 | 50 |
| Value | 55 | 54 |
| Quality | 59 | 52 |
| Growth | 51 | 62 |
| Safety | 22 | 27 |
| Sentiment | 59 | 55 |
| Quality details | ||
| Profitability | 64 | 43 |
| Cash Truth | 53 | 61 |
Daewon Pharmaceutical vs Reyon PharmaceuticalDaewon Pharmaceutical vs Il Dong PharmaceuticalDaewon Pharmaceutical vs PharmGen ScienceDaewon Pharmaceutical vs Rohto PharmaceuticalAdd a third stock →
Full analyses: Daewon Pharmaceutical · Towa Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100